Properties of bcr-abl-transformed mouse 12B1 cells secreting interleukin-2 and granulocyte-macrophage colony-stimulating factor: I. Derivation, genetic stability, oncogenicity and immunogenicity

By      

International Journal of Oncology, Vol. 40, Iss. 5, 2012-01 ,pp. : 1668-1676

Spandidos Publications

Access to resources Recommend Favorite

Local application of granulocyte-macrophage colony stimulating factor (GM-CSF) for the treatment of oral mucositis

By Sprinzl G.M.   Galvan O.   de Vries A.   Ulmer H.   Gunkel A.R.   Lukas P.   Thumfart W.F.  

European Journal of Cancer, Vol. 37, Iss. 16, 2001-11 ,pp. : 2003-2009

Elsevier

Access to resources Recommend Favorite

Growth stimulation of non-small cell lung cancer xenografts by granulocyte-macrophage colony-stimulating factor (GM-CSF)

By Oshika Y.   Nakamura M.   Abe Y.   Fukuchi Y.   Yoshimura M.   Itoh M.   Ohnishi Y.   Tokunaga T.   Fukushima Y.   Hatanaka H.   Kijima H.   Yamazaki H.   Tamaoki N.   Ueyama Y.  

European Journal of Cancer, Vol. 34, Iss. 12, 1998-11 ,pp. : 1958-1961

Elsevier

Access to resources Recommend Favorite

Phase I trial of infusional cyclophosphamide, doxorubicin, and etoposide plus granulocyte-macrophage colony stimulating factor (GM-CSF) in non-hodgkin’s lymphoma

By Sparano Joseph   Negassa Abdissa   Lansigan Erick   Locke Robin   Silva Chamath   Wiernik Peter  

Medical Oncology, Vol. 22, Iss. 3, 2005-09 ,pp. : 257-267

Humana Press, Inc

Access to resources Recommend Favorite

Treatment of Poor Prognosis Epidemic Kaposi's Sarcoma with Doxorubicin, Bleomycin, Vindesine and Recombinant Human Granulocyte-Monocyte Colony Stimulating Factor (rh GM-CSF)

By Bakker P.J.M.   Danner S.A.   Napel C.H.H.t.   Kroon F.P.   Sprenger H.G.   van Leusen R.   Meenhorst P.L.   Muusers A.   Veenhof C.H.N.  

European Journal of Cancer, Vol. 31, Iss. 2, 1995-01 ,pp. : 188-192

Elsevier

Access to resources Recommend Favorite